Surgery Websites
Vascular & Endovascular Surgery »  Meet the Team »  Vascular Surgeons »  Adam Oskowitz M.D., Ph.D.
Adam Oskowitz M.D., Ph.D.

Adam Oskowitz M.D., Ph.D.

  • Associate Professor of Surgery
  • Division of Vascular and Endovascular Surgery

Contact Information

Division of Vascular and Endovascular Surgery, UCSF
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
[email protected]
Open Popup

Education

1996-2000 Johns Hopkins University B.S. Economics/Pre-Medicine

2000-2001 Dartmouth M.S. Public Health

2002-2009 Tulane University M.D., Ph.D. Cell and Molecular Biology

Residencies

  • 2009-2010 University of California Los Angeles, Intern, General Surgery
  • 2010-2013 University of California Los Angeles, Resident, General Surgery
  • 2013-2014 University of California Los Angeles, Chief Resident, General Surgery

Fellowships

  • 2014-2016 University of California Los Angeles, Fellow, Vascular Surgery

Board Certifications

  • American Board of Surgery, General Surgery

Clinical Expertise

Research Interests

  • Aortic Aneurysms
  • Biologic Scaffolds and Stents
  • Stem Cell Biology

Foreign Languages Spoken

  • Spanish

Biography

Adam Oskowitz M.D., Ph.D. graduated from Johns Hopkins University with a Bachelors degree in Economics. He then attained a masters degree in public health at Dartmouth College. He completed his medical degree and gained his Ph.D. at Tulane University. His doctoral dissertation focused on elucidating the molecular mechanism that regulate stem cells, under the direction of Dr Darwin Prockop. He finished his general surgery residency at the University of California, Los Angeles (UCLA) in 2014. Dr. Oskowitz completed the fellowship in Vascular and Endovascular Surgery at UCLA and is now on faculty at UCSF.

Research Overview

Dr. Oskowitz is interested in developing novel treatments for Aortic Aneurysms using stem cells. His is currently studying the molecular mechanisms that govern the therapeutic benefits of stem cells while developing unique ways to utilize cell based therapy.

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 34
Data provided by UCSF Profiles, powered by CTSI
  1. C. Woodford, D. Zarkowsky, A.Z. Oskowitz, R. Shahverdyan, B. Wu, S.M. Vartanian. Vein Compliance is Superior to Vein Diameter for Predicting Unassisted AVF Maturation. Journal of Vascular Surgery. 2023 Sep 1; 78(3):e57. View in PubMed
  2. Lopez JL, Ramirez JL, Phu TA, Duong P, Bouchareychas L, Kuhrau CR, Lin PY, Eckalbar WL, Barczak AJ, Rudolph JD, Maliskova L, Conte MS, Vartanian SM, Raffai RL, Oskowitz AZ. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes. PLoS One. 2023; 18(2):e0281371. View in PubMed
  3. Sonali Shaligram, Jose Luis Lopez, Pei-Yu Lin, Patrick Ho, April Huang, Qizhi Tang, Adam Z. Oskowitz. A Chimeric Antigen Receptor Targeting Malonaldehyde-modified Low-density lipoprotein Cholesterol Activates Regulatory T Cells in the Presence of Human Atherosclerotic Plaque. JVS Vascular Science. 2022 Jun 1. View in PubMed
  4. Jose Luis Lopez, Pei-Yu Lin, Sonali Shaligram, April Huang, Pierce Hadley, Qizhi Tang, Adam Oskowitz. Regulatory T Cells Suppress Aortic Aneurysm Growth in Mice through Local Tissue Changes and Lymph Node Colonization. JVS Vascular Science. 2022 Jun 1. View in PubMed
  5. Jose L Lopez, Pei-Yu Lin, Sonali Shaligram, April Huang, Pierce Hadley, Qizhi Tang, Adam Z Oskowitz. Abstract 124: Regulatory T Cells Suppress Aortic Aneurysm Growth In Mice Through Local Tissue Changes And Lymph Node Colonization. Arteriosclerosis Thrombosis and Vascular Biology. 2022 May 1; 42(Suppl_1):a124-a124. View in PubMed
  6. View All Publications

In the News

  • Adam Oskowitz, MD, PhD Awarded $400,000 R21 Trailblazer Award

    UCSF Division of Vascular & Endovascular Surgery - Lauren Washburn - April 09, 2020
    Adam Oskowitz, MD, PhD, assistant professor in the Division of Vascular & Endovascular Surgery, has been awarded an R21 Trailblazer Award by the National Institute of Biomedical Imaging and Bioengineering, a 3-year grant that supports high-risk, high-impact research. The goals for the research grant are to generate a Chimeric Antigen Receptor to direct T-regulatory cells to injured aortic tissue, and reduce the vascular inflammation that results in abdominal aortic aneurysm growth and [...]

 

 
Site Directory
    X